Company profile for RS Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RS Therapeutics, in a research project the drug release from different diclofenac preparations compounded by pharmacies or sold as finished product were compared. The study showed that the drug release from compounding bases and the commercial product were slow. To overcome this problem, a water-based nanotechnology foam which enhances drug release and ultimately skin penetration significantly was developed.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
21002 RPO Terwillegar Edmonton, AB, T6R 2V4
Telephone
Telephone
1 (877) 336-2623
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/07/02/2907789/0/en/Eledon-to-Participate-in-the-Leerink-Partners-Therapeutics-Forum-I-I-and-Metabolism.html

GLOBENEWSWIRE
02 Jul 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty